(+)-schisandrin B multiple interactions ISO Ube2b (Rattus norvegicus) 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of UBE2B mRNA] CTD PMID:31150632 1,2-dichloroethane decreases expression EXP 6480464 ethylene dichloride results in decreased expression of UBE2B mRNA CTD PMID:28960355 1,2-dimethylhydrazine decreases expression EXP 6480464 1 and 2-Dimethylhydrazine results in decreased expression of UBE2B mRNA CTD PMID:22206623 1,3-dinitrobenzene increases expression ISO Ube2b (Rattus norvegicus) 6480464 3-dinitrobenzene results in increased expression of UBE2B mRNA CTD PMID:24140754 2,3',4,4',5-Pentachlorobiphenyl increases expression EXP 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Ube2b (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of UBE2B mRNA CTD PMID:19490992 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of UBE2B mRNA] CTD PMID:15034205 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of UBE2B mRNA CTD PMID:15034205 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of UBE2B mRNA CTD PMID:21570461 2,3,7,8-Tetrachlorodibenzofuran increases expression ISO Ube2b (Rattus norvegicus) 6480464 2 more ... CTD PMID:32109520 3,4-methylenedioxymethamphetamine decreases expression ISO Ube2b (Rattus norvegicus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of UBE2B mRNA CTD PMID:30071829 3H-1,2-dithiole-3-thione decreases expression ISO Ube2b (Rattus norvegicus) 6480464 1 and 2-dithiol-3-thione results in decreased expression of UBE2B mRNA CTD PMID:19162173 acetylsalicylic acid increases expression ISO Ube2b (Rattus norvegicus) 6480464 Aspirin results in increased expression of UBE2B mRNA CTD PMID:12800193 acrylamide decreases expression ISO Ube2b (Rattus norvegicus) 6480464 Acrylamide results in decreased expression of UBE2B mRNA CTD PMID:28959563 acrylamide increases expression ISO UBE2B (Homo sapiens) 6480464 Acrylamide results in increased expression of UBE2B mRNA CTD PMID:32763439 aflatoxin B1 decreases methylation ISO UBE2B (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of UBE2B gene CTD PMID:27153756 ammonium chloride affects expression ISO Ube2b (Rattus norvegicus) 6480464 Ammonium Chloride affects the expression of UBE2B mRNA CTD PMID:16483693 ammonium chloride increases expression ISO Ube2b (Rattus norvegicus) 6480464 Ammonium Chloride results in increased expression of UBE2B mRNA CTD PMID:12420312 arsenite(3-) multiple interactions ISO UBE2B (Homo sapiens) 6480464 arsenite promotes the reaction [G3BP1 protein binds to UBE2B mRNA] CTD PMID:32406909 arsenous acid multiple interactions EXP 6480464 Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of UBE2B mRNA] CTD PMID:29095437 arsenous acid decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of UBE2B mRNA CTD PMID:29095437 arsenous acid increases expression ISO UBE2B (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of UBE2B mRNA CTD PMID:25258189 benzo[a]pyrene increases expression ISO Ube2b (Rattus norvegicus) 6480464 Benzo(a)pyrene results in increased expression of UBE2B mRNA CTD PMID:21839799 benzo[a]pyrene increases methylation ISO UBE2B (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of UBE2B promoter CTD PMID:27901495 benzo[a]pyrene multiple interactions EXP 6480464 AHR protein inhibits the reaction [Benzo(a)pyrene results in increased expression of UBE2B mRNA] CTD PMID:15034205 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of UBE2B mRNA CTD PMID:15034205 and PMID:35678645 benzo[a]pyrene diol epoxide I decreases expression ISO UBE2B (Homo sapiens) 6480464 7 more ... CTD PMID:19150397 and PMID:20018196 berberine decreases expression ISO UBE2B (Homo sapiens) 6480464 Berberine results in decreased expression of UBE2B mRNA CTD PMID:27311644 bis(2-chloroethyl) sulfide decreases expression EXP 6480464 Mustard Gas results in decreased expression of UBE2B mRNA CTD PMID:26392148 bisphenol A increases expression ISO Ube2b (Rattus norvegicus) 6480464 bisphenol A results in increased expression of UBE2B mRNA CTD PMID:25181051 bisphenol A decreases expression ISO UBE2B (Homo sapiens) 6480464 bisphenol A results in decreased expression of UBE2B mRNA CTD PMID:33670352 butyric acid increases expression ISO Ube2b (Rattus norvegicus) 6480464 Butyric Acid results in increased expression of UBE2B mRNA CTD PMID:12800193 cannabidiol increases expression ISO UBE2B (Homo sapiens) 6480464 Cannabidiol results in increased expression of UBE2B mRNA CTD PMID:28025562 carbamazepine affects expression ISO UBE2B (Homo sapiens) 6480464 Carbamazepine affects the expression of UBE2B mRNA CTD PMID:25979313 carbon nanotube decreases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 celastrol increases expression ISO UBE2B (Homo sapiens) 6480464 celastrol results in increased expression of UBE2B mRNA CTD PMID:17010675 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of UBE2B gene CTD PMID:20938992 chrysene decreases expression EXP 6480464 chrysene results in decreased expression of UBE2B mRNA CTD PMID:26377693 cisplatin multiple interactions ISO UBE2B (Homo sapiens) 6480464 Cisplatin inhibits the reaction [Piroxicam results in decreased expression of UBE2B mRNA] CTD PMID:21858171 cobalt dichloride increases expression ISO UBE2B (Homo sapiens) 6480464 cobaltous chloride results in increased expression of UBE2B mRNA CTD PMID:19376846 copper(II) sulfate increases expression ISO UBE2B (Homo sapiens) 6480464 Copper Sulfate results in increased expression of UBE2B mRNA CTD PMID:19549813 coumestrol multiple interactions ISO UBE2B (Homo sapiens) 6480464 [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of UBE2B mRNA CTD PMID:19167446 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of UBE2B mRNA CTD PMID:19770486 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of UBE2B mRNA CTD PMID:17998272 diarsenic trioxide increases expression ISO UBE2B (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of UBE2B mRNA CTD PMID:25258189 diarsenic trioxide decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of UBE2B mRNA CTD PMID:29095437 diarsenic trioxide multiple interactions EXP 6480464 Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of UBE2B mRNA] CTD PMID:29095437 diazinon increases methylation ISO UBE2B (Homo sapiens) 6480464 Diazinon results in increased methylation of UBE2B gene CTD PMID:22964155 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of UBE2B mRNA CTD PMID:21266533 dicrotophos decreases expression ISO UBE2B (Homo sapiens) 6480464 dicrotophos results in decreased expression of UBE2B mRNA CTD PMID:28302478 dorsomorphin multiple interactions ISO UBE2B (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UBE2B mRNA CTD PMID:27188386 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of UBE2B mRNA CTD PMID:25896364 Enterolactone multiple interactions ISO UBE2B (Homo sapiens) 6480464 [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of UBE2B mRNA CTD PMID:19167446 ethanol affects expression EXP 6480464 Ethanol affects the expression of UBE2B mRNA CTD PMID:30319688 ethanol increases expression EXP 6480464 Ethanol results in increased expression of UBE2B mRNA CTD PMID:30319688 ethyl methanesulfonate increases expression ISO UBE2B (Homo sapiens) 6480464 Ethyl Methanesulfonate results in increased expression of UBE2B mRNA CTD PMID:23649840 fenvalerate increases expression ISO Ube2b (Rattus norvegicus) 6480464 fenvalerate results in increased expression of UBE2B mRNA CTD PMID:30307764 folic acid multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of UBE2B gene CTD PMID:20938992 formaldehyde increases expression ISO UBE2B (Homo sapiens) 6480464 Formaldehyde results in increased expression of UBE2B mRNA CTD PMID:20655997 gedunin increases expression ISO UBE2B (Homo sapiens) 6480464 gedunin results in increased expression of UBE2B mRNA CTD PMID:17010675 gentamycin increases expression ISO Ube2b (Rattus norvegicus) 6480464 Gentamicins results in increased expression of UBE2B mRNA CTD PMID:33387578 glafenine decreases expression ISO Ube2b (Rattus norvegicus) 6480464 Glafenine results in decreased expression of UBE2B mRNA CTD PMID:24136188 ketamine increases expression ISO Ube2b (Rattus norvegicus) 6480464 Ketamine results in increased expression of UBE2B mRNA CTD PMID:20080153 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of UBE2B gene CTD PMID:20938992 L-methionine decreases expression EXP 6480464 Methionine deficiency results in decreased expression of UBE2B mRNA CTD PMID:35314295 lead(0) affects splicing ISO UBE2B (Homo sapiens) 6480464 Lead affects the splicing of UBE2B mRNA CTD PMID:28903495 lipopolysaccharide decreases expression EXP 6480464 Lipopolysaccharides results in decreased expression of UBE2B mRNA CTD PMID:12057914 lipopolysaccharide multiple interactions ISO Ube2b (Rattus norvegicus) 6480464 [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of UBE2B mRNA CTD PMID:16415329 mercury dichloride increases expression ISO Ube2b (Rattus norvegicus) 6480464 Mercuric Chloride results in increased expression of UBE2B mRNA CTD PMID:16507785 metformin multiple interactions EXP 6480464 Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of UBE2B mRNA] CTD PMID:29095437 methyl methanesulfonate increases expression ISO UBE2B (Homo sapiens) 6480464 Methyl Methanesulfonate results in increased expression of UBE2B mRNA CTD PMID:23649840 methylmercury chloride increases expression ISO UBE2B (Homo sapiens) 6480464 methylmercuric chloride results in increased expression of UBE2B mRNA CTD PMID:28001369 monocrotaline increases expression ISO Ube2b (Rattus norvegicus) 6480464 Monocrotaline results in increased expression of UBE2B mRNA CTD PMID:18801959 N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine multiple interactions ISO Ube2b (Rattus norvegicus) 6480464 [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of UBE2B mRNA CTD PMID:16415329 ozone decreases expression EXP 6480464 Ozone results in decreased expression of UBE2B mRNA CTD PMID:12763052 and PMID:16183385 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of UBE2B mRNA CTD PMID:17562736 paracetamol increases expression ISO Ube2b (Rattus norvegicus) 6480464 Acetaminophen results in increased expression of UBE2B mRNA CTD PMID:33387578 paracetamol increases expression ISO UBE2B (Homo sapiens) 6480464 Acetaminophen results in increased expression of UBE2B mRNA CTD PMID:21420995 paraquat decreases expression ISO Ube2b (Rattus norvegicus) 6480464 Paraquat results in decreased expression of UBE2B mRNA CTD PMID:18198484 perfluorooctanoic acid increases expression ISO Ube2b (Rattus norvegicus) 6480464 perfluorooctanoic acid results in increased expression of UBE2B mRNA CTD PMID:19162173 and PMID:21318169 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of UBE2B mRNA CTD PMID:35678645 phenobarbital increases expression ISO Ube2b (Rattus norvegicus) 6480464 Phenobarbital results in increased expression of UBE2B mRNA CTD PMID:19162173 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of UBE2B mRNA CTD PMID:21335049 phlorizin decreases expression EXP 6480464 Phlorhizin results in decreased expression of UBE2B mRNA CTD PMID:22538082 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of UBE2B mRNA CTD PMID:23811191 piroxicam multiple interactions ISO UBE2B (Homo sapiens) 6480464 Cisplatin inhibits the reaction [Piroxicam results in decreased expression of UBE2B mRNA] CTD PMID:21858171 piroxicam decreases expression ISO UBE2B (Homo sapiens) 6480464 Piroxicam results in decreased expression of UBE2B mRNA CTD PMID:21858171 ranitidine multiple interactions ISO Ube2b (Rattus norvegicus) 6480464 [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of UBE2B mRNA CTD PMID:16415329 resveratrol multiple interactions ISO UBE2B (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of UBE2B mRNA CTD PMID:23557933 SB 431542 multiple interactions ISO UBE2B (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UBE2B mRNA CTD PMID:27188386 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of UBE2B mRNA CTD PMID:16014739 and PMID:16322246 Tesaglitazar increases expression ISO Ube2b (Rattus norvegicus) 6480464 tesaglitazar results in increased expression of UBE2B mRNA CTD PMID:21515302 tetrachloromethane multiple interactions ISO Ube2b (Rattus norvegicus) 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of UBE2B mRNA] CTD PMID:31150632 tetrachloromethane increases expression ISO Ube2b (Rattus norvegicus) 6480464 Carbon Tetrachloride results in increased expression of UBE2B mRNA CTD PMID:31150632 thioacetamide increases expression ISO Ube2b (Rattus norvegicus) 6480464 Thioacetamide results in increased expression of UBE2B mRNA CTD PMID:34492290 trichostatin A increases expression ISO UBE2B (Homo sapiens) 6480464 trichostatin A results in increased expression of UBE2B mRNA CTD PMID:26272509 trichostatin A multiple interactions ISO UBE2B (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UBE2B mRNA CTD PMID:27188386 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of UBE2B mRNA CTD PMID:17292431 valproic acid affects expression ISO UBE2B (Homo sapiens) 6480464 Valproic Acid affects the expression of UBE2B mRNA CTD PMID:25979313 valproic acid increases expression ISO UBE2B (Homo sapiens) 6480464 Valproic Acid results in increased expression of UBE2B mRNA CTD PMID:23179753 and PMID:29154799 vorinostat affects expression ISO UBE2B (Homo sapiens) 6480464 vorinostat affects the expression of UBE2B mRNA CTD PMID:27188386 zinc atom multiple interactions ISO UBE2B (Homo sapiens) 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of UBE2B mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO UBE2B (Homo sapiens) 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of UBE2B mRNA CTD PMID:18593933